New research from Michigan Medicine could help clinicians identify which patients are more likely to continue to use opioids after surgery recovery.
Kelly Malcom is the lead research communicator for Michigan Medicine. She promotes the work of the U-M basic science departments and the Institute for Healthcare Policy and Innovation via various channels. She has more than 15 years of experience in strategic communications, marketing, and health and science writing.
A new mouse and human tissue study identifies an enzyme critical for normal wound healing
A study in rats has revealed the presence of naturally occurring DMT, an increasingly popular hallucinogen.
People with chronic pain or fibromyalgia who engage in low-risk drinking habits report fewer symptoms and improved function than teetotalers.
U-M researchers lead the field in successful protein creation, a tactic that could lead to a newer, more effective class of drugs.